Abaxis Overview
- Year Founded
-
1989
- Status
-
Acquired/Merged
- Employees
-
656
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.96B
Abaxis General Information
Description
Manufacturer of diagnostic instruments intended to serve veterinary point-of-care services. The company's products include blood analyzing systems that consist of a compact, chemistry analyzer capable of electrolytes, blood gas, and immunoassays, a complete, easy-to-use hematology analyzer, and a series of 8-cm diameter single-use plastic discs, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices.
Contact Information
Website
www.abaxis.com(Operating Subsidiary)
Corporate Office
- 3240 Whipple Road
- Union City, CA 94587
- United States
Corporate Office
- 3240 Whipple Road
- Union City, CA 94587
- United States
Abaxis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 31-Jul-2018 | $1.96B | Completed | Generating Revenue | ||
| 2. IPO | 23-Jan-1992 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Generating Revenue |
Abaxis Comparisons
Industry
Financing
Details
Abaxis Competitors (19)
One of Abaxis’s 19 competitors is Nidek, a Corporation company based in Gamagori, Japan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nidek | Corporation | Gamagori, Japan | ||||
| RetinaScope | Venture Capital-Backed | Purmerend, Netherlands | ||||
| Idexx Laboratories | Formerly VC-backed | Westbrook, ME | ||||
| Norlase | Venture Capital-Backed | Ballerup, Denmark | ||||
| Abbott | Corporation | Abbot Park, IL |
Abaxis Patents
Abaxis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018195530-A1 | Systems, devices and methods for microfluidic analysis | Inactive | 21-Apr-2017 | ||
| WO-2018140953-A1 | Solution-based plasmon specific-binding partner assays and metallic nanostructures | Inactive | 30-Jan-2017 | ||
| WO-2018005464-A1 | Devices with modified conduits | Inactive | 27-Jun-2016 | ||
| WO-2017024163-A1 | Signal amplification in solution-based plasmonic specific-binding partner assays | Inactive | 04-Aug-2015 | ||
| EP-3126835-A2 | Compositions and methods for identifying ehrlichia species | Active | 04-Apr-2014 | G01N33/56911 |
Abaxis Signals
Abaxis Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alloy Ventures | Venture Capital | Minority | ||
| Delphi Ventures (California) | Venture Capital | Minority | ||
| MedVenture Associates | Venture Capital | Minority | ||
| NeoMed Management | Venture Capital | Minority | ||
| Sequoia Capital | Venture Capital | Minority |
Abaxis Investments & Acquisitions (2)
Abaxis’s most recent deal was a Merger/Acquisition with QCR & Trio Diagnostics. The deal was made on 17-Nov-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| QCR & Trio Diagnostics | 17-Nov-2014 | Merger/Acquisition | Other Devices and Supplies | ||
| Scandinavian Micro Biodevices | 11-Feb-2011 | Corporate | Other Commercial Products |
Abaxis ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
13.77 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Abaxis FAQs
-
When was Abaxis founded?
Abaxis was founded in 1989.
-
Where is Abaxis headquartered?
Abaxis is headquartered in Union City, CA.
-
What is the size of Abaxis?
Abaxis has 656 total employees.
-
What industry is Abaxis in?
Abaxis’s primary industry is Diagnostic Equipment.
-
Is Abaxis a private or public company?
Abaxis is a Private company.
-
What is the current valuation of Abaxis?
The current valuation of Abaxis is .
-
What is Abaxis’s current revenue?
The current revenue for Abaxis is .
-
How much funding has Abaxis raised over time?
Abaxis has raised $27.5M.
-
Who are Abaxis’s investors?
Alloy Ventures, Delphi Ventures (California), MedVenture Associates, NeoMed Management, and Sequoia Capital have invested in Abaxis.
-
Who are Abaxis’s competitors?
Nidek, RetinaScope, Idexx Laboratories, Norlase, and Abbott are some of the 19 competitors of Abaxis.
-
When was Abaxis acquired?
Abaxis was acquired on 31-Jul-2018.
-
Who acquired Abaxis?
Abaxis was acquired by Zoetis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process